Mode
Text Size
Log in / Sign up

Long-term bilateral THA study finds no osteolysis with ceramic or HXLPE bearings in patients under 65

Long-term bilateral THA study finds no osteolysis with ceramic or HXLPE bearings in patients under 6…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider ceramic or HXLPE bearings for younger THA patients based on long-term RCT data showing no osteolysis and high survival.

This randomized controlled trial followed 250 patients (500 hips) under age 65 undergoing bilateral primary total hip arthroplasty for a mean of 25.5 years (range 20-30). All patients received a cementless, metaphyseal-fitting anatomic femoral stem. Hips were randomized to receive either an alumina ceramic-on-ceramic (C-O-C) bearing or an alumina ceramic-on-highly cross-linked polyethylene (C-O-HXLPE) bearing, creating a within-patient comparison.

No hip in either group developed osteolysis over the follow-up period. The mean polyethylene penetration rate for the HXLPE liners was 0.041 ± 0.005 mm/year. Implant survival rates at mean 25.5 years were high: 96.8% (95% CI, 92 to 100) for the femoral component and 97.2% (95% CI, 92 to 100) for the acetabular component in the C-O-C group, and 97.6% (95% CI, 92 to 100) for both components in the C-O-HXLPE group. Clinical and functional scores (Harris Hip Score, WOMAC, UCLA activity score) improved significantly (P < 0.05) in both groups at final follow-up.

Regarding safety, no ceramic femoral head or acetabular liner fractures were reported. The study did not report other specific adverse event rates or discontinuation data. Key limitations include the lack of a direct statistical comparison of survival rates between the two bearing groups and the specific population of patients under 65 undergoing bilateral procedures, which may limit generalizability to older patients or unilateral cases. The RCT design and long-term follow-up provide strong within-patient evidence for bearing performance in this specific cohort.

Study Details

Study typeRct
Sample sizen = 250
EvidenceLevel 2
Follow-up240.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: We determined the long-term (≥ 20 years) clinical outcomes of metaphyseal-fitting anatomic cementless implants with alumina ceramic-on-ceramic (C-O-C) or alumina ceramic-on-highly cross-linked polyethylene (C-O-HXLPE) bearings. METHODS: Consecutive primary total hip arthroplasty (THA) procedures were performed in 250 patients (500 hips; 140 men, 110 women) aged < 65 years. This is a series of bilateral THA patients who were randomized to receive a C-O-C bearing on one side and a C-O-HXLPE on the contralateral side. The mean age at the time of THA was 45 years (range, 31 to 65), with a mean follow-up of 25.5 years (range, 20 to 30). Osteolysis was assessed using radiographs and computed tomography scans, whereas polyethylene wear was measured using a computer software program. RESULTS: There was no hip in either group that had osteolysis. The mean polyethylene penetration rate of the HXLPE liner was 0.041 ± 0.005 mm/year. The survival rate in the C-O-C bearing group was 96.8% (95% confidence interval [CI], 92 to 100) for the femoral component and 97.2% (95% CI, 92 to 100) for the acetabular component at a mean of 25.5 years of follow-up. In the C-O-HXLPE bearing group, the survival rate for both femoral and acetabular components was 97.6% (95% CI, 92 to 100) at a mean of 25.5 years of follow-up. The clinical and functional results (Harris Hip Score, Western Ontario and McMaster Universities Osteoarthritis Index score, and University of California, Los Angeles, activity score) improved significantly (P < 0.05) at the final follow-up in both groups. CONCLUSIONS: At a mean follow-up of 25.5 years, a metaphyseal-fitting anatomic cementless femoral stem with alumina C-O-C or alumina C-O-HXLPE bearings demonstrated excellent long-term function, with no osteolysis and no ceramic femoral head or acetabular liner fractures.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.